Prolonged fasting, in the case of religious rituals like Ramadan, may pose a higher risk of hypoglycemia in diabetic patients. Clinical studies demonstrate that patients treated with sulfonylureas have a relatively higher risk of hypoglycemia. Rapid-acting insulin has been proven to efficiently control the blood glucose level and lower incidence of hypoglycemia. During Ramadan, insulin treatment with structured diabetes education for point of care glucose monitoring is a vital tool for reducing uneventful episodes. Eli Lilly and Docplexus have organized an interactive Webinar on 18th March 2020 at 2:30 p.m.
In this webinar session, Professor Abdul Jabbar and Dr. Mohamad Hassanein will discuss the recommendations for fasting during Ramadan for people with diabetes. We invite you to share your questions which will be answered by the speakers at the end of the session. PP-HI-IN-0273…
